Product Information
CHILD LORATADINE 5 MG/5 ML SOL is a generic product labeled by Major Pharmaceuticals, priced at $0.0414 per ML under NDC 00904676720. Its NADAC has been published 372 times since Aug 21, 2019.
FDA first approved this application on Aug 20, 2004.
Strength
5 mg/5mL
Manufacturer
Major PharmaceuticalsNDC
00904676720
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LORATADINEApproval Type
Generic (ANDA)
FDA Application
ANDA075728FDA Approved
8/20/2004
On Market Since
2/12/2019
Price Statistics
The NADAC for CHILD LORATADINE 5 MG/5 ML SOL has been published 372 times since Aug 21, 2019, and over the history we have for it it has risen 9.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0414 per ML |
|---|---|
| All-time high | $0.0471 (Dec 14, 2022) |
| All-time low | $0.0338 (Nov 20, 2024) |
| 52-week high | $0.0428 |
| 52-week low | $0.0393 |
| Median price | $0.0409 |
| Average price | $0.0407 |
| Largest weekly change | +25.7% (Aug 21, 2024) |
| Weeks tracked | 372 |
| Tracking since | Aug 21, 2019 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Major Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Loratadine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHILD LORATADINE 5 MG/5 ML SOL?
The current National Average Drug Acquisition Cost (NADAC) for CHILD LORATADINE 5 MG/5 ML SOL, manufactured by Major Pharmaceuticals, is $0.0414 per ML (NDC 00904676720), effective Sep 30, 2026.
How has the price of CHILD LORATADINE 5 MG/5 ML SOL changed over time?
Over the history we have for it, the NADAC for CHILD LORATADINE 5 MG/5 ML SOL has risen 9.6%. It has been tracked across 372 weekly CMS publications since Aug 21, 2019.
What are the highest and lowest recorded NADAC prices for CHILD LORATADINE 5 MG/5 ML SOL?
Since Aug 21, 2019, the NADAC for CHILD LORATADINE 5 MG/5 ML SOL has ranged from a low of $0.0338 (Nov 20, 2024) to a high of $0.0471 (Dec 14, 2022), with a median of $0.0409 per ML.
Are there cheaper alternatives to CHILD LORATADINE 5 MG/5 ML SOL?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, HM CHILD LORATADINE 5 MG/5 ML, is $0.0370 per ML — about 11% below CHILD LORATADINE 5 MG/5 ML SOL.
Who manufactures CHILD LORATADINE 5 MG/5 ML SOL?
CHILD LORATADINE 5 MG/5 ML SOL (NDC 00904676720) is labeled by Major Pharmaceuticals, and CMS classifies it as a generic product.